IL26 and psoriasis: Strikingly, the majority of IL26+ T cells in both nonlesional and lesional skin of psoriasis patients as well as in healthy skin expressed the TRM marker CD103 (ITGAE) (Supplementary Fig. 2C), indicating that IL26+ TH17 intermediates in the skin derive from skin-resident rather than circulating T cells.